Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 15, 2015 - Issue 9
Submit an article Journal homepage
360
Views
17
CrossRef citations to date
0
Altmetric
Review

The clinical use of DNA methyltransferase inhibitors in myelodysplastic syndromes

Abdallah Abou ZahrDivision of Hematology Oncology, Mount Sinai Beth Israel, New York, NY, USA
,
Ehab Saad AldinDepartment of Diagnostic Radiology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA
,
Lisa BarbarottaDepartment of Medicine, Division of Hematology, Yale University, 333 Cedar Street, PO Box 208028, New Haven, CT 06520-8028, USA
,
Nikolai PodoltsevDepartment of Medicine, Division of Hematology, Yale University, 333 Cedar Street, PO Box 208028, New Haven, CT 06520-8028, USA
&
Amer M ZeidanDepartment of Medicine, Division of Hematology, Yale University, 333 Cedar Street, PO Box 208028, New Haven, CT 06520-8028, USACorrespondence[email protected]
Pages 1019-1036 | Published online: 17 Aug 2015

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Russell Lewis, Jan Philipp Bewersdorf & Amer M Zeidan. (2021) Clinical Management of Anemia in Patients with Myelodysplastic Syndromes: An Update on Emerging Therapeutic Options. Cancer Management and Research 13, pages 645-657.
Read now
Nora Chokr, Alexander B. Pine, Jan Philipp Bewersdorf, Rory M. Shallis, Maximilian Stahl & Amer M. Zeidan. (2019) Getting personal with myelodysplastic syndromes: is now the right time?. Expert Review of Hematology 12:4, pages 215-224.
Read now
Maximilian Stahl & Amer M. Zeidan. (2017) Management of lower-risk myelodysplastic syndromes without del5q: current approach and future trends. Expert Review of Hematology 10:4, pages 345-364.
Read now
Amer M. Zeidan, Maximilian Stahl & Rami Komrokji. (2016) Emerging biological therapies for the treatment of myelodysplastic syndromes. Expert Opinion on Emerging Drugs 21:3, pages 283-300.
Read now

Articles from other publishers (13)

Shaochuan Liu, Qian Sun & Xiubao Ren. (2023) Novel strategies for cancer immunotherapy: counter-immunoediting therapy. Journal of Hematology & Oncology 16:1.
Crossref
Xianmei Meng, Na Liu, Yanbin Jia, Kerui Gong, Jingjie Zhang, Wei Zhang, Guo Shao & Tong Dang. (2020) DNMT3B Expression Might Contribute to Abnormal Methylation of RASSF1A in Lager Colorectal Adenomatous Polyps. Gastroenterology Research and Practice 2020, pages 1-16.
Crossref
Sijie Li, Changhong Ren, Christopher Stone, Ankush Chandra, Jiali Xu, Ning Li, Cong Han, Yuchuan Ding, Xunming Ji & Guo Shao. (2020) Hamartin: An Endogenous Neuroprotective Molecule Induced by Hypoxic Preconditioning. Frontiers in Genetics 11.
Crossref
Amer M. Zeidan, Rory M. Shallis, Rong Wang, Amy Davidoff & Xiaomei Ma. (2019) Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it. Blood Reviews 34, pages 1-15.
Crossref
Amer M. Zeidan, Smith Giri, Michelle DeVeaux, Samir K. Ballas & Vu H. Duong. (2018) Systematic review and meta-analysis of the effect of iron chelation therapy on overall survival and disease progression in patients with lower-risk myelodysplastic syndromes. Annals of Hematology 98:2, pages 339-350.
Crossref
Ramazan Rezaei, Saeed Aslani & Mahdi Mahmoudi. 2019. Pharmacoepigenetics. Pharmacoepigenetics 573 586 .
Rory M. Shallis & Amer M. Zeidan. (2018) More is less, less is more, or does it really matter? The curious case of impact of azacitidine administration schedules on outcomes in patients with myelodysplastic syndromes. BMC Hematology 18:1.
Crossref
Rory M. Shallis, Rami Ahmad & Amer M. Zeidan. (2018) The genetic and molecular pathogenesis of myelodysplastic syndromes. European Journal of Haematology 101:3, pages 260-271.
Crossref
Amer M. Zeidan, Maximilian Stahl, Mikkael A. Sekeres, David P. Steensma, Rami S. Komrokji & Steven D. Gore. (2017) A call for action: Increasing enrollment of untreated patients with higher-risk myelodysplastic syndromes in first-line clinical trials. Cancer 123:19, pages 3662-3672.
Crossref
William Rae. (2016) Indications to Epigenetic Dysfunction in the Pathogenesis of Common Variable Immunodeficiency. Archivum Immunologiae et Therapiae Experimentalis 65:2, pages 101-110.
Crossref
Maximilian Stahl & Amer M. Zeidan. (2017) Hypomethylating agents in combination with histone deacetylase inhibitors in higher risk myelodysplastic syndromes: Is there a light at the end of the tunnel?. Cancer 123:6, pages 911-914.
Crossref
Amer M. Zeidan, Amy J. Davidoff, Jessica B. Long, Xin Hu, Rong Wang, Xiaomei Ma, Cary P. Gross, Gregory A. Abel, Scott F. Huntington, Nikolai A. Podoltsev, Uno Hajime, Thomas Prebet & Steven D. Gore. (2016) Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes . British Journal of Haematology 175:5, pages 829-840.
Crossref
Xuan Qiu, Yuanxin Liang, Rani S. Sellers, Roman Perez-Soler & Yiyu Zou. (2016) Toxicity and Pharmacokinetic Studies of Aerosolized Clinical Grade Azacitidine. Clinical Lung Cancer 17:3, pages 214-222.e1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.